Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?
Saifi O, Breen WG, Lester SC, Rule WG, Stish B, Rosenthal A, Munoz J, Herchko SM, Murthy HS, Lin Y, Bansal R, Hathcock MA, Bennani NN, Paludo J, Wang Y, Khurana A, Bisneto JCV, Johnston PB, Ansell SM, Iqbal M, Tun H, Ayala E, Kharfan-Dabaja MA, Hoppe BS, Peterson JL. Saifi O, et al. Among authors: hathcock ma. Radiother Oncol. 2022 Jan;166:171-179. doi: 10.1016/j.radonc.2021.11.031. Epub 2021 Dec 7. Radiother Oncol. 2022. PMID: 34890736 Free article.
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.
Gile JJ, Lopez CL, Ruan GJ, Hathcock MA, Abeykoon JP, Heimgartner JR, Baumann NA, McMahon MM, Micallef IN, Johnston PB, Bisneto JCV, Porrata LF, Paludo J, Ansell SM, Hogan WJ, Witzig TE. Gile JJ, et al. Among authors: hathcock ma. Blood Cancer J. 2021 Mar 26;11(3):65. doi: 10.1038/s41408-021-00452-0. Blood Cancer J. 2021. PMID: 33771971 Free PMC article.
The impact of obesity and body weight on the outcome of patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel.
Wudhikarn K, Bansal R, Khurana A, Hathcock MA, Bennani NN, Paludo J, Villasboas JC, Wang Y, Johnston PB, Ansell SM, Lin Y. Wudhikarn K, et al. Among authors: hathcock ma. Blood Cancer J. 2021 Jul 1;11(7):124. doi: 10.1038/s41408-021-00515-2. Blood Cancer J. 2021. PMID: 34210955 Free PMC article. No abstract available.
Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphoma.
Khurana A, Hathcock M, Habermann TM, Al Saleh AS, Gandhi S, Truong T, Bennani NN, Paludo J, Villasboas JC, Ansell SM, Inwards DJ, Porrata LF, Johnston PB, Micallef I, Lin Y. Khurana A, et al. Am J Hematol. 2021 Oct 1;96(10):E386-E389. doi: 10.1002/ajh.26293. Epub 2021 Jul 29. Am J Hematol. 2021. PMID: 34260759 Free article. No abstract available.
The impact of granulocyte colony stimulating factor on patients receiving chimeric antigen receptor T-cell therapy.
Barreto JN, Bansal R, Hathcock MA, Doleski CJ, Hayne JR, Truong TA, Nedved AN, Ansell SM, Bennani NN, Paludo J, Villasboas JC, Lin Y, Johnston PB. Barreto JN, et al. Among authors: hathcock ma. Am J Hematol. 2021 Oct 1;96(10):E399-E402. doi: 10.1002/ajh.26313. Epub 2021 Aug 14. Am J Hematol. 2021. PMID: 34350612 Free article. No abstract available.
Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel.
Wudhikarn K, Bansal R, Khurana A, Hathcock MA, Braksick SA, Bennani NN, Paludo J, Villasboas JC, Wang Y, Johnston PB, Ansell SM, Lin Y. Wudhikarn K, et al. Among authors: hathcock ma. Am J Hematol. 2021 Nov 1;96(11):E427-E430. doi: 10.1002/ajh.26330. Epub 2021 Sep 7. Am J Hematol. 2021. PMID: 34424554 Free article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 34700461
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience.
Melody M, Gandhi S, Saunders H, Abdel-Rahman Z, Hastings J, Lengerke Diaz P, Gannon N, Truong T, Hathcock M, Khurana A, Johnston P, Ansell S, Bennani N, Paludo J, Bisneto JV, Wang Y, Rosenthal A, Foran J, Ayala E, Murthy HS, Roy V, Castro JE, Lin Y, Kharfan-Dabaja MA. Melody M, et al. Among authors: hathcock m. Leuk Lymphoma. 2022 Jun;63(6):1363-1368. doi: 10.1080/10428194.2022.2030475. Epub 2022 Feb 3. Leuk Lymphoma. 2022. PMID: 35109766
Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT.
Breen WG, Hathcock MA, Young JR, Kowalchuk RO, Bansal R, Khurana A, Bennani NN, Paludo J, Villasboas Bisneto JC, Wang Y, Ansell SM, Peterson JL, Johnston PB, Lester SC, Lin Y. Breen WG, et al. Among authors: hathcock ma. J Hematol Oncol. 2022 Mar 26;15(1):36. doi: 10.1186/s13045-022-01256-w. J Hematol Oncol. 2022. PMID: 35346315 Free PMC article.
Peak absolute lymphocyte count after CAR-T infusion predicts clinical response in aggressive lymphoma.
Bansal R, Novo M, Al Saleh AS, Guerrico AG, Zhang H, Shao Z, Babadi E, Martinez KE, McCoy GA, Hathcock MA, Khurana A, Bennani NN, Paludo J, Wang Y, Ansell SM, Johnston PB, Villasboas JC, Lin Y. Bansal R, et al. Among authors: hathcock ma. Am J Hematol. 2022 Jul;97(7):E241-E244. doi: 10.1002/ajh.26561. Epub 2022 Apr 14. Am J Hematol. 2022. PMID: 35385152 Free article. No abstract available.
73 results